Bullous pemphigoid (BP), which has no FDA-approved targeted therapies, leads to reddening of the skin and the formation of ...

Pemphigus is an autoimmune bullous disease, in which autoantibodies react with the cell–cell adhesion structures, desmosomes, causing blisters and erosions on the oral mucosa and skin.

Blue Trust Inc. trimmed its holdings in argenx SE (NASDAQ:ARGX – Free Report) by 55.4% in the 4th quarter, HoldingsChannel ...

Valeo Financial Advisors LLC bought a new stake in argenx SE (NASDAQ:ARGX – Free Report) during the 4th quarter, according to ...

Vesiculo-bullous diseases such as pemphigus vulgaris, erosive lichen planus, and varicella zoster may mimic SJS. Behcet's and Reiter's syndrome may have ocular and genital lesions that can be ...

exfoliative dermatitis and bullous eruptions of the skin, including pemphigus, in which they have often been life saving. 1–4 It is in these conditions, however, largely as a result of the use ...

Dupilumab, an interleukin-4 receptor antagonist, is expected to decrease the type 2 inflammation seen in bullous pemphigoid.

Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoidIf approved, Dupixent would be the first and only ...

Regeneron and Sanofi said an FDA green light would make Dupixent the first targeted medicine in the U.S. for bullous pemphigoid, a debilitating and relapsing skin disease with underlying type 2 ...